| Literature DB >> 30665439 |
Manita Yimcharoen1, Suwatsin Kittikunnathum1, Chawannut Suknikorn1, Wichuda Nak-On1, Petcharee Yeethong1, Tracy G Anthony2, Piyawan Bunpo3.
Abstract
BACKGROUND: Ascorbic acid is a water-soluble chain breaking antioxidant. It scavenges free radicals and reactive oxygen species (ROS), which are produced during metabolic pathways. Exercise can produce an imbalance between ROS and antioxidants, leading to oxidative stress-related tissue damages. This study was designed to determine the effects of ascorbic acid supplementation on circulating biomarkers of oxidative stress and muscle damage following a single bout of exercise.Entities:
Keywords: Exercise; Glucose; Inflammation; Muscle damage; Oxidative stress markers; Vitamin C
Mesh:
Substances:
Year: 2019 PMID: 30665439 PMCID: PMC6341721 DOI: 10.1186/s12970-019-0269-8
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Fig. 1Crossover study design. Overnight fasted female subjects ingested 2 capsules containing placebo or 1000 mg of ascorbic acid (AA) 5 min prior to exercise. The exercise bout was performed indoors on a stationary bicycle for 30 min at an intensity corresponding to 65–75% of maximum heart rate. A 1-week wash out period separated the two exercise bouts
Characteristics of female subjects before exercise
| Parameter | Placebo | Ascorbic Acid (1000 mg) |
|---|---|---|
| Age, years | 22.4 ± 2.2 | |
| Ethnicity/race, n | Southeast Asian (thai) 19 | |
| Height, m | 1.6 ± 0.02 | |
| Weight, kg | 53.3 ± 2.7 | 53.3 ± 2.6 |
| BMI | 21.2 ± 0.8 | 21.2 ± 0.8 |
| Maximum heart rate (beat/min) | 144 ± 2.7 | 144 ± 2.5 |
| % of maximum heart rate | 71 ± 1.6 | 71 ± 1.7 |
| Distance, km | 8.2 ± 0.2 | 8.1 ± 0.1 |
| Calories, kcal | 134 ± 3.3 | 133 ± 3.2 |
Values are means ± SE; n = 19 per cohort. m, meter; kg, kilogram; min, minute; km, kilometer; kcal, kilocalories
Fig. 2Plasma concentrations of albumin (a) total protein (b) glucose (c) and ascorbic acid (d) in females ingesting ascorbic acid or placebo before exercise. Values are means ± SE; n = 19 per cohort. The p-values indicate the results of a Bonferroni post-hoc analysis
Antioxidant status measured in the peripheral blood of females ingesting ascorbic acid or placebo before exercise
| Test | Placebo | Ascorbic Acid (1000 mg) | ||||
|---|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | 30 min post-exercise | Pre-exercise | Post-exercise | 30 min post-exercise | |
| TAS, mM Trolox equivalent | 1.27 ± 0.04 | 1.29 ± 0.02 | 1.33 ± 0.02 | 1.28 ± 0.03 | 1.27 ± 0.02 | 1.31 ± 0.03 |
| FRAP, μM FeSO4 equivalent | 74.0 ± 3.29 | 77.0 ± 3.54 | 78.1 ± 3.59 | 73.5 ± 3.25 | 77.2 ± 3.15 | 81.2 ± 3.35 a, |
| Plasma TBARS, μmol/g protein | 0.042 ± 0.003 | 0.038 ± 0.003 | 0.044 ± 0.007 | 0.039 ± 0.004 | 0.031 ± 0.002 a, 0.048, b, | 0.030 ± 0.002 a, |
| Glutathione peroxidase (GPx), U/g Hb | 133 ± 7.1 | 135 ± 7.6 | 128 ± 6.8 | 133 ± 5.3 | 130 ± 6.4 | 138 ± 7.3 |
| Superoxide dismutase, U/g Hb | 2609 ± 263 | 3168 ± 461 | 3450 ± 454a, p = 0.022 | 2605 ± 375 | 2726 ± 340 | 2794 ± 364 |
| Catalase, U/g Hb | 90 ± 11.1 | 90 ± 12.4 | 90 ± 16.2 | 94 ± 11.8 | 91 ± 16.0 | 92 ± 12.0 |
The exercise bout was performed indoors on a stationary bicycle for 30 min at intensity corresponding to 65–75% of maximum heart rate. Values are means ± SE; n = 19 per cohort. The p-values indicate the results of a Bonferroni post-hoc analysis. acompared with pre-exercise value (within group); bcompared with the same time point (in between group). TAS, total antioxidant status; FRAP, ferric reducing ability of plasma; TBARS thiobarbituric acid reactive substances; U/g Hb, unit per gram of hemoglobin
Circulating markers of muscle damage and inflammation in females ingesting ascorbic acid or placebo before exercise
| Test | Placebo | Ascorbic Acid (1000 mg) | ||||
|---|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | 30 min post-exercise | Pre-exercise | Post-exercise | 30 min post-exercise | |
| hsCRP, mg/L | 0.68 ± 0.13 | 0.67 ± 0.13 | 0.62 ± 0.12 | 0.57 ± 0.12 | 0.63 ± 0.10 | 0.52 ± 0.11 |
| LDH, U/L | 126 ± 5.3 | 124 ± 5.0 | 129 ± 4.8 | 128 ± 4.5 | 130 ± 4.9 | 132 ± 5.6 |
| Total CK, U/L | 93.5 ± 8.1 | 111.9 ± 10.2a, | 111.7 ± 10.2a, | 92.4 ± 13.7 | 101.0 ± 14.1 | 109.3 ± 14.3a, |
| CK-MB, U/L | 19.7 ± 2.8 | 22.6 ± 3.8 | 15.6 ± 2.8 | 18.4 ± 2.6 | 21.3 ± 2.8 | 15.1 ± 2.0 |
The exercise bout was performed indoors on a stationary bicycle for 30 min at intensity corresponding to 65–75% of maximum heart rate. Values are means ± SE; n = 19 per cohort. The p-values indicate the results of a Bonferroni post-hoc analysis. acompared with pre-exercise value (within group). hsCRP, high-sensitivity C-reactive protein; LDH, lactate dehydrogenase; CK, creatine kinase; CK-MB, creatine kinase-muscle and brain isoenzyme